Want to see SPRY full AI Analyst Report?
ARS Pharmaceuticals (SPRY) Q2 2024 Earnings Report
SPRY Q2 2024 EPS Results
- Actual EPS
- -$0.13
- Consensus EPS
- -$0.11
- Beat/Miss
- Missed by -$0.02
- One Year Ago EPS
- -$0.18
SPRY Q2 2024 Revenue Results
- Actual Revenue
- $500.00K
- Expected Revenue
- $1.00M
- Beat/Miss
- Missed by -$500.00K
- YoY Revenue Growth
- +4900.00%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/06/2024
- Time
- After Close
- Conference Call
- Tuesday, August 6, 2024
SPRY Upcoming Earnings
ARS Pharmaceuticals's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
SPRY Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | -0.30- | -0.52 | ― | ― |
| Aug 13, 2026 | 2026 (Q2) | -0.48-0.63 | -0.46 | -36.96% (-0.17) | |
| May 15, 2026 | 2026 (Q1) | -0.52-0.61 | -0.35 | -74.29% (-0.26) | |
| Mar 09, 2026 | 2025 (Q4) | -0.43-0.41 | 0.48 | -185.42% (-0.89) | |
| Nov 10, 2025 | 2025 (Q3) | -0.45-0.52 | -0.2 | -160.00% (-0.32) | |
| Aug 13, 2025 | 2025 (Q2) | -0.46-0.46 | -0.13 | -253.85% (-0.33) | |
| May 14, 2025 | 2025 (Q1) | -0.34-0.35 | -0.11 | -218.18% (-0.24) | |
| Mar 20, 2025 | 2024 (Q4) | -0.240.48 | -0.07 | 785.71% (+0.55) | |
| Nov 13, 2024 | 2024 (Q3) | -0.14-0.20 | -0.16 | -25.00% (-0.04) | |
| Aug 06, 2024 | 2024 (Q2) | -0.11-0.13 | -0.18 | 27.78% (+0.05) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
